Evidence map›Paper›PMID 36691869›Full record

ArticleMicrobial biotechnology2023

Development of genetic tools for heterologous protein expression in a pentose-utilizing environmental isolate of Pseudomonas putida.

Rahul Gauttam, Thomas Eng, Zhiying Zhao, Qurrat Ul Ain Rana, Blake A Simmons, Yasuo Yoshikuni, Aindrila Mukhopadhyay, Steven W Singer

Abstract read
In one paragraph

Article in Microbial biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Assessing horizontal gene transfer in the rhizosphere ofApplied and environmental microbiology · 2024
    Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rahul GauttamThe Joint BioEnergy Institute, Emeryville, California, USA.
Thomas EngThe Joint BioEnergy Institute, Emeryville, California, USA.ORCID 0000-0002-4974-3863
Zhiying ZhaoJoint Genome Institute, Berkeley, California, USA.
Qurrat Ul Ain RanaThe Joint BioEnergy Institute, Emeryville, California, USA.
Blake A SimmonsThe Joint BioEnergy Institute, Emeryville, California, USA.
Yasuo YoshikuniJoint Genome Institute, Berkeley, California, USA.
Aindrila MukhopadhyayThe Joint BioEnergy Institute, Emeryville, California, USA.
Steven W SingerThe Joint BioEnergy Institute, Emeryville, California, USA.ORCID 0000-0002-4229-8314

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pseudomonas putida has emerged as a promising host for the conversion of biomass-derived sugars and aromatic intermediates into commercially relevant biofuels and bioproducts. Most of the strain development studies previously published have focused on P. putida KT2440, which has been engineered to produce a variety of non-native bioproducts. However, P. putida is not capable of metabolizing pentose sugars, which can constitute up to 25% of biomass hydrolysates. Related P. putida isolates that metabolize a larger fraction of biomass-derived carbon may be attractive as complementary hosts to P. putida KT2440. Here we describe genetic tool development for P. putida M2, a soil isolate that can metabolize pentose sugars. The functionality of five inducible promoter systems and 12 ribosome binding sites was assessed to regulate gene expression. The utility of these expression systems was confirmed by the production of indigoidine from C6 and C5 sugars. Chromosomal integration and expression of non-native genes was achieved by using chassis-independent recombinase-assisted genome engineering (CRAGE) for single-step gene integration of biosynthetic pathways directly into the genome of P. putida M2. These genetic tools provide a foundation to develop hosts complementary to P. putida KT2440 and expand the ability of this versatile microbial group to convert biomass to bioproducts.

Indexed as

Pseudomonas putidaBiosynthetic PathwaysSugarsSugars

Identifiers

PMID36691869
PMCPMC9948227

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.